You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
29
May 24
Annual General Meeting
30
Sep 24
Publication half-yearly financial report
14
Mar 24
Publication annual financial report
09
Nov 23
Publication quarterly financial report (call-date Q3)
10
Aug 23
15
Jun 23
11
May 23
Publication quarterly financial report (call-date Q1)
28
Mar 23
Nov 22
Aug 22
Jun 22
May 22
24
Mar 22
Nov 21
Publication quarterly statement (call-date Q3)
Aug 21
16
Jun 21
12
May 21
25
Mar 21
27
Nov 20
Extraordinary General Meeting
13
Aug 20
Jun 20
07
May 20
Publication quarterly statement (call-date Q1)
Apr 20
19
Nov 19
Aug 19
May 19
08
Mar 19
Nov 18
Aug 18
May 18
23
Mar 18
Nov
2017
Aug
May
Mar
Nov 16
Aug 16
May 16
10 April 2024
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
14 March 2024
Epigenomics AG publishes financial results for fiscal year 2023
12 March 2024
6 March 2024
15 February 2024
Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
31 January 2024
Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board
Jahresabschluss 2023
10 August 2023
Halbjahresfinanzbericht 2023
31 May 2023
Q1 statement / Q1 financial report 2023
28 April 2023
Jahresfinanzbericht 2022
Annual financial report 2022
25 August 2020
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): Kaufen
16 April 2018
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): Buy
19 December 2017
Original-Research: Epigenomics AG (von First Berlin Equity Research GmbH): BUY
6 October 2017
21 April 2011
Original-Research: Epigenomics AG (von MIDAS Research): Langfr. Kaufen
15 November 2010
Original-Research: Epigenomics AG (von MIDAS Research): Langfristig Kaufen